News

QuickChek – November 5, 2021

Markets
0 min read



Information Services Group Announces Third-Quarter 2021 Results

Information Services Group announced financial results for the third quarter ended September 30, 2021

Listen to the Audio Replay of Results Call

See today’s research report from Joe Gomes, Senior Research Analyst, and Joshua Zoepfel, Research Associate at Noble Capital Markets

Research, News & Market Data on ISG

Watch recent presentation from ISG



Salem Media Group, Inc. Announces Third Quarter 2021 Total Revenue of $66.0 Million

Salem Media Group announced its results for the three and nine months ended September 30, 2021

See today’s research report from Michael Kupinski, Director of Research at Noble Capital Markets

Research, News & Market Data on Salem Media

Watch recent presentation from Salem Media



TradeStation Group To Become Public Company Through Business Combination With Quantum FinTech

Quantum Fintech (QFTA) announced their intent to take TradeStation, the Florida based online broker and proprietary software company, public via a $1.43B SPAC Merger

News & Market Data on TradeStation



Eagle Bulk Shipping Inc. Reports Record Results for the Third Quarter of 2021

Eagle Bulk Shipping announced financial results for the quarter ended September 30, 2021

See today’s research report from Poe Fratt, Senior Research Analyst at Noble Capital Markets

Research, News & Market Data on Eagle Bulk Shipping

Watch recent presentation from Eagle Bulk Shipping



QuoteMedia Q3 2021 Financial Results and Investors’ Conference Call November 10, 2021

QuoteMedia announced that its earnings for its quarter ended September 30, 2021 will be released the morning of November 10, 2021

Research, News & Market Data on QuoteMedia



Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational COVID-19 Vaccine COVAXIN™ (BBV152) for Children Ages 2-18 Years

Ocugen announced hat it has submitted a request to the U.S. Food and Drug Administration for Emergency Use Authorization (EUA) of Ocugen’s COVID-19 vaccine candidate BBV152, known as COVAXIN™ outside of the U.S., for pediatric use

Research, News & Market Data on Ocugen

Watch recent presentation from Ocugen

 

Stay up to date. Follow us:

 
Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy